A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis
Public ClinicalTrials.gov record NCT00988221. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 24 Week Randomized, Double-blind, Placebo-controlled Withdrawal Trial With a 16 Week Open-label lead-in Phase, and 64 Week Open-label Follow-up, to Evaluate the Effect on Clinical Response and the Safety of Tocilizumab in Patients With Active Polyarticular-course Juvenile Idiopathic Arthritis
Study identification
- NCT ID
- NCT00988221
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 188 participants
Conditions and interventions
Conditions
Interventions
- Tocilizumab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 29, 2009
- Primary completion
- Nov 29, 2011
- Completion
- Jan 27, 2013
- Last update posted
- Jul 25, 2017
2009 – 2013
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Connecticut Children's Medical Center; 5E Clinical Trials Unit | Hartford | Connecticut | 06106 | — |
| Children's National Medical Center; Pediatric Rheumatology | Washington D.C. | District of Columbia | 20010-2970 | — |
| Delray Research Associates | Delray Beach | Florida | 33484 | — |
| Miami Children's Hospital | Miami | Florida | 33155-3009 | — |
| The University of Chicago;Department of Pediatrics | Chicago | Illinois | 60649 | — |
| University of Louisville Research Foundation, Inc; Kosair Charities Pediatric Clinical Research Unit | Louisville | Kentucky | 40202 | — |
| Children's Hospital | New Orleans | Louisiana | 70118 | — |
| Hackensack University Medical Center; Pediatric Rheumatology | Hackensack | New Jersey | 07601 | — |
| Cincinnati Children'S Hospital Medical Center; Division of Rheumatology | Cincinnati | Ohio | 45229-3039 | — |
| Healthcare Research Consultants | Tulsa | Oklahoma | 74135 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00988221, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 25, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00988221 live on ClinicalTrials.gov.